Care of vision and ocular health in diabetic members of a national diabetes organization: A cross-sectional study

Table 1 Practice guidelines for HbA1c treatment target and management of ocular health in patients with diabetes.

	Norway*	United Kingdom^†	USA^‡	Australia^§
HbA1c treatment target
Children/Type 1 < 18 years		< 7.5%	< 7%
Type 1 > 18 years		< 7.5%	< 7%
Type 2		6.5–7.5%	< 7%
Younger (<80 years)	< 7%		< 7%
Older (>80 years)	< 9%		< 7%
Screening for diabetic retinopathy
First examination
Children/Type 1<18 years		At age 12 years		At puberty
< 30 years/Type 1	5 years after diagnosis	At diagnosis	5 years after diagnosis	At diagnosis
> 30 years/Type 2	At diagnosis	At diagnosis	At diagnosis	At diagnosis
Follow-up in absence of retinopathy
Children/Type 1 < 18 years		Annually	Annually	At least biannually
< 30 years/Type 1	Annually	Annually	Annually	At least biannually
> 30 years/Type 2	Annually/Biannually	Annually	Annually	At least biannually
Follow-up in retinopathy	Individual	Individual	Individual	Individual

Norwegian practice guidelines compared to practice guidelines in the United Kingdom, USA and Australia at the time (2005) of the study.
*The Norwegian College of General Practitioners, ^†National Institute for Clinical Excellence, ^‡American Diabetes Association, ^§National Health and Medical Research Council

ISSN: 1472-6963